Evidence map›Paper›PMID 27507159›Full record

ArticleJournal of nanobiotechnology2016

Impact of degradable nanowires on long-term brain tissue responses.

Lina Gällentoft, Lina M E Pettersson, Nils Danielsen, Jens Schouenborg, Christelle N Prinz, Cecilia Eriksson Linsmeier

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Impact of nanoparticles on neuron biology: current research trends.International journal of nanomedicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lina GällentoftDepartment of Experimental Medical Science, Medical Faculty, Neuronano Research Center (NRC), Lund University, Scheelevägen 2, 223 81, Lund, Sweden. lina.gallentoft@med.lu.se.
Lina M E PetterssonDepartment of Experimental Medical Science, Medical Faculty, Neuronano Research Center (NRC), Lund University, Scheelevägen 2, 223 81, Lund, Sweden.
Nils DanielsenDepartment of Experimental Medical Science, Medical Faculty, Neuronano Research Center (NRC), Lund University, Scheelevägen 2, 223 81, Lund, Sweden.
Jens SchouenborgDepartment of Experimental Medical Science, Medical Faculty, Neuronano Research Center (NRC), Lund University, Scheelevägen 2, 223 81, Lund, Sweden.
Christelle N PrinzDepartment of Experimental Medical Science, Medical Faculty, Neuronano Research Center (NRC), Lund University, Scheelevägen 2, 223 81, Lund, Sweden. christelle.prinz@ftf.lth.se.
Cecilia Eriksson LinsmeierDepartment of Experimental Medical Science, Medical Faculty, Neuronano Research Center (NRC), Lund University, Scheelevägen 2, 223 81, Lund, Sweden. cecilia.eriksson_linsmeier@med.lu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA promising approach to improve the performance of neural implants consists of adding nanomaterials, such as nanowires, to the surface of the implant. Nanostructured interfaces could improve the integration and communication stability, partly through the reduction of the cell-to-electrode distance. However, the safety issues of implanted nanowires in the brain need to be evaluated and understood before nanowires can be used on the surface of implants for long periods of time. To this end we here investigate whether implanted degradable nanowires offer any advantage over non-degradable nanowires in a long-term in vivo study (1 year) with respect to brain tissue responses.

resultsThe tissue response after injection of degradable silicon oxide (SiOx)-coated gallium phosphide nanowires and biostable hafnium oxide-coated GaP nanowires into the rat striatum was compared. One year after nanowire injection, no significant difference in microglial or astrocytic response, as measured by staining for ED1 and glial fibrillary acidic protein, respectively, or in neuronal density, as measured by staining for NeuN, was found between degradable and biostable nanowires. Of the cells investigated, only microglia cells had engulfed the nanowires. The SiOx-coated nanowire residues were primarily seen in aggregated hypertrophic ED1-positive cells, possibly microglial cells that have fused to create multinucleated giant cells. Occasionally, degradable nanowires with an apparently intact shape were found inside single, small ED1-positive cells. The biostable nanowires were found intact in microglia cells of both phenotypes described.

conclusionThe present study shows that the degradable nanowires remain at least partly in the brain over long time periods, i.e. 1 year; however, no obvious bio-safety issues for this degradable nanomaterial could be detected.

Indexed as

Absorbable ImplantsAnimalsAntigens, NuclearAstrocytesBiomarkersCell FusionCoated Materials, BiocompatibleCorpus StriatumEctodysplasinsFemaleGalliumGene ExpressionGlial Fibrillary Acidic ProteinHafniumMicrogliaNanowiresAntigens, NuclearBiomarkersCoated Materials, BiocompatibleEctodysplasinsGalliumgallium phosphideGlial Fibrillary Acidic ProteinHafniumhafnium oxideNerve Tissue ProteinsOxidesPhosphinesRbfox3 protein, ratSilicon DioxideBiocompatibilityBiomaterialBrainForeign body reactionImmunohistochemistryNanomedicineNanowiresNeural interfacesTissue responses

Identifiers

PMID27507159
PMCPMC4979107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.